9/12/25 +59% atyr watch day 8
9/12/25 +59% atyr watch day 8
YouTube9 hr 4 min
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Consider a long-term position in quantum computing leader IonQ (IONQ), which claims a multi-year technological lead and strategic partnerships with companies like NVIDIA. A high-risk, short-term opportunity may exist by betting against aTyr Pharma (ATYR) ahead of its upcoming binary Phase 3 data release, given strong allegations of prior data manipulation. Investors holding IBM or Microsoft (MSFT) for their quantum efforts should re-evaluate, as this analysis suggests they are years behind competitors. The insights also highlight a significant long-term risk to the security of cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH) from advancing quantum technology. Finally, NVIDIA's (NVDA) partnership with IonQ could represent a significant future growth driver, strengthening its moat in high-performance computing.

Detailed Analysis

IonQ (IONQ)

The majority of the transcript is a recording of IonQ's Investor Day presentation, where the company laid out an extremely bullish case for its future.

  • Technological Leadership: IonQ claims to be the undisputed leader in quantum computing, with a 5+ year lead over competitors like IBM and Microsoft. Their technology is based on trapped ions, which they state provides superior qubit performance and fidelity.
  • Key Acquisitions:
    • Oxford Ionics: This acquisition provides electronic qubit control technology, which allows for higher performance, better scalability using standard semiconductor supply chains, and superior unit economics.
    • LightSync: This acquisition is for quantum networking technology, enabling the connection of multiple quantum computers to create data-center scale systems. The company compares this to NVIDIA's highly successful acquisition of Mellanox.
    • ID Quantique: This acquisition forms the basis of their quantum networking security business.
  • Aggressive Roadmap: The company has a public roadmap to reach 2 million physical qubits by 2030, which they claim is years ahead of any competitor's stated goals. They project they can build this system for low tens of millions of dollars, while competitors would need billions.
  • Dual Business Model:
    • Quantum Computing (QC): They are already delivering "quantum advantage" (solving problems faster than classical computers) on specific applications. A partnership with NVIDIA, AstraZeneca, and AWS resulted in a 20x speed-up for a drug discovery problem.
    • Quantum Networking (QN): They offer Quantum Key Distribution (QKD), a commercially available product that provides theoretically unbreakable security. This addresses the "harvest now, decrypt later" threat, where encrypted data is stolen today to be broken by future quantum computers.
  • Competitive Landscape: The presentation repeatedly dismisses competitors like IBM and Microsoft as being far behind, accusing them of making "splashy announcements" that are not backed by functional technology. They claim Microsoft's quantum computer has "never turned on."
  • Strong Financials & Talent: The company highlighted a strong balance sheet with nearly $1.7 billion in cash to fund growth and acquisitions. They are also attracting top talent from government agencies (IARPA) and major tech companies (IBM, JP Morgan, Microsoft).

Takeaways

  • Strong Bull Case (from the company): IonQ presents itself as the dominant force in the quantum revolution, with superior technology, a clearer path to scale, and a "here and now" revenue stream from quantum security.
  • High-Growth Potential: The presentation paints a picture of a company poised to lead a multi-trillion dollar industry shift, similar to how NVIDIA grew from a gaming company to an AI powerhouse.
  • Validation through Partnerships: Collaborations with major players like NVIDIA, AWS, AstraZeneca, and government bodies like DARPA and the Air Force Research Lab lend credibility to their technological claims.
  • Investor Consideration: While the presentation is extremely compelling, investors should remember it is a company presenting its own story. The investment thesis is long-term and carries the high risk associated with a pioneering technology sector.

aTyr Pharma (ATYR)

The speaker at the beginning and end of the podcast is intensely focused on an upcoming Phase 3 data release for aTyr Pharma, which is described as a binary event.

  • Bearish Sentiment: The speaker expresses extreme skepticism and a bearish outlook on the company.
  • Analysis of Past Data: The speaker conducts a deep-dive analysis of the company's previously published Phase 2 trial data and alleges signs of data manipulation.
    • Claims that the company selectively excluded patients from the analysis to make the drug's dose-response appear more favorable.
    • Suggests the placebo group's results were made to look worse than they were.
    • Points out numerous inconsistencies in patient counts across different charts and publications, calling the data "fugazi" and "Guantanamo data."
    • The speaker states, "This is a million times worse" than what he was accused of, implying serious potential fraud.
  • Market Action: The speaker notes that the puts are pumping, meaning options traders are betting on the stock price falling. The implied volatility is extremely high (over 800%), indicating the market expects a massive price move.

Takeaways

  • Significant Risk Warning: The speaker's analysis serves as a major red flag for investors. The allegations of data manipulation in prior trials suggest the upcoming Phase 3 results are highly risky.
  • Potential Short Opportunity: The speaker's bearish stance and detailed analysis imply a potential opportunity for short-sellers or those buying puts, betting that the Phase 3 data will be negative and the stock will fall sharply.
  • Extreme Caution Advised: For long-term investors, this analysis suggests extreme caution is warranted. A binary biotech event is already risky, and these allegations of data irregularities amplify that risk considerably.

NVIDIA (NVDA)

NVIDIA is mentioned frequently as a key partner and as an analogy for IonQ's strategy.

  • Strategic Partner: NVIDIA is collaborating with IonQ on hybrid quantum-classical computing applications, most notably in a drug discovery project with AstraZeneca that demonstrated a significant speed-up.
  • The "Mellanox" Analogy: IonQ's acquisition of LightSync (for networking) is repeatedly compared to NVIDIA's acquisition of Mellanox. The point is that just as high-speed networking was crucial for scaling GPUs for the AI revolution, quantum networking is crucial for scaling quantum computers, and IonQ is positioning itself to capture that value.
  • Jensen's "Tonal Change": The presentation claims that NVIDIA CEO Jensen Huang's perspective on quantum computing has become more positive, and that this change was "driven almost all" by IonQ's progress and their partnership.

Takeaways

  • Expanding Ecosystem: NVIDIA is not just an AI chip company; it is actively positioning itself as a key infrastructure player in the next wave of computing: quantum.
  • Future Growth Vector: While still a small part of its business, NVIDIA's involvement with the leader in quantum computing could represent a significant future growth driver and strengthen its moat in high-performance computing.

IBM (IBM) & Microsoft (MSFT)

These two tech giants are consistently referenced as IonQ's main, but lagging, competitors.

  • Bearish Competitive View: From IonQ's perspective, both IBM and Microsoft are at least five years behind in quantum technology.
  • "Fake News": IonQ's CEO dismisses their competitors' announcements as "splashy press releases" and "fake news," urging investors to "double click" on the details.
  • Specific Claims: It was claimed that Microsoft's quantum machine has "never turned on" and that IBM's roadmap to 2,000 logical qubits by 2033 is roughly where IonQ will be in 2028.

Takeaways

  • Contrarian Viewpoint: The transcript offers a strong contrarian take on the quantum leadership of IBM and Microsoft.
  • Due Diligence Required: Investors who own IBM or Microsoft for their quantum computing exposure should perform due diligence on IonQ's claims to better understand the competitive landscape.

Bitcoin (BTC) & Ethereum (ETH)

These cryptocurrencies are mentioned as being vulnerable to the power of quantum computing.

  • The Quantum Threat: The presentation predicts that within the next few years, IonQ's technology will be able to run Shor's algorithm effectively.
  • Compromised Security: This would allow for the breaking of current encryption standards like ECC 256, which underpins the security of cryptocurrencies like Bitcoin and Ethereum.

Takeaways

  • Long-Term Risk Factor: The rise of fault-tolerant quantum computing represents a significant, long-term technological risk to the fundamental security and value proposition of many current cryptocurrencies. Holders should monitor the progress of both quantum computing and quantum-resistant cryptography.

Other Stock Mentions

Several other stocks were mentioned briefly with limited context.

  • Joby (JOBY) & Super Micro (SMCI): Mentioned in passing as being "up" for the day.
  • Newegg (NEGG): The speaker notes having "made a lot of money on Newegg."
  • Open Door (OPEN): The speaker expressed bearish sentiment, stating "I'd short open you."
Ask about this postAnswers are grounded in this post's content.
Video Description
let's get this $
About Martin Shkreli
Martin Shkreli

Martin Shkreli

By @realmartinshkreli

Investing, music, science, math, technology, programming, medicine and more!